參考文獻(xiàn)/References:
[1] 黃浩然,衛(wèi)楊文祥,章家皓,等.Piezo1介導(dǎo)的機(jī)械應(yīng)力刺激在抗骨質(zhì)疏松中的作用[J].中國組織工程研究,2023,27(17):2716-2722.
[2] 田佳慶,何敏聰,韋雨柔,等.激素性股骨頭壞死囊性變分布規(guī)律及病理特點(diǎn)[J].中國組織工程研究,2023,27(31):4996-5001.
[3] 李群,胡智星,張彥瓊,等.轉(zhuǎn)錄組學(xué)數(shù)據(jù)挖掘結(jié)合“臨床-動(dòng)物”研究驗(yàn)證識(shí)別激素性股骨頭壞死全病程的證素標(biāo)志基因[J].中國中藥雜志,2024,49(5):1343-1352.
[4] 劉凱,郭美玲,朱婷.振動(dòng)療法對(duì)骨質(zhì)疏松骨折患者骨礦含量、骨鈣素及骨折愈合的影響[J].中國現(xiàn)代醫(yī)學(xué)雜志,2023,33(15):8-14.
[5] 魏騰飛,何曉銘,韋雨柔,等.Piezo1在激素性和酒精性股骨頭壞死骨組織中的差異表達(dá)[J].中國組織工程研究,2023,27(2):270-275.
[6] TIAN J Q,WEI T F,WEI Y R,et al.Effect of whole body vibration therapy in the rat model of steroid-induced osteonecrosis of the femoral head[J].Front Cell Dev Biol,2023,11:1251634.
[7] 楊麗麗,康靜,劉建勛,等.Piezo1通道在心血管疾病中的作用及中醫(yī)藥研究進(jìn)展[J].中國中藥雜志,2022,47(24):6533-6540.
[8] 王媛,趙星成,王永春,等.Piezo通道在心血管系統(tǒng)中的作用[J].心臟雜志,2022,34(5):573-578.
[9] RANADE S S,QIU Z,WOO S H,et al.Piezo1,a mechanically activated ion channel,is required for vascular development in mice[J].Proc Natl Acad Sci U S A,2014,111(28):10347-10352.
[10] CHEN S,LI Z,CHEN D,et al.Piezo1-mediated mechanotransduction promotes entheseal pathological new bone formation in ankylosing spondylitis[J].Ann Rheum Dis,2023,82(4):533-545.
[11] 張曼,張苗苗,李易,等.牙齒移動(dòng)過程中Piezo1對(duì)壓力側(cè)牙周組織內(nèi)IL-1β、IL-6及IL-17的影響[J].口腔醫(yī)學(xué)研究,2023,39(2):135-140.
[12] 陳國輝,李亞星,張暉,等.Piezo機(jī)械敏感性離子通道在骨關(guān)節(jié)系統(tǒng)中的作用[J].中國修復(fù)重建外科雜志,2024,38(2):240-248.
[13] 韋雨柔,田佳慶,何憲順,等.慢病毒沉默Piezo1蛋白與人骨髓間充質(zhì)干細(xì)胞成骨分化及TAZ的表達(dá)[J].中國組織工程研究,2024,28(1):12-19.
[14] SUN W,CHI S,LI Y,et al.The mechanosensitive Piezo1 channel is required for bone formation[J].Elife,2019,8:e47454.
[15] DZAMUKOVA M,BRUNNER T M,MIOTLA-ZAREBSKA J,et al.Mechanical forces couple bone matrix mineralization with inhibition of angiogenesis to limit adolescent bone growth[J].Nat Commun,2022,13(1):3059.
[16] HU Y,TIAN H,CHEN W,et al.The critical role of the Piezo1/beta-catenin/ATF4 axis on the stemness of Gli1+ BMSCs during simulated microgravity-induced bone loss[J].Adv Sci(Weinh),2023,10(32):e2303375.
[17] LIU Y,TIAN H,HU Y,et al.Mechanosensitive Piezo1 is crucial for periosteal stem cell-mediated fracture healing[J].Int J Biol Sci,2022,18(10):3961-3980.
[18] RONG S,ZHANG L,WANG J,et al.Regulatory role of Piezo1 channel in endothelium-dependent hyperpolarization-mediated vasorelaxation of small resistance vessels and its anti-inflammatory action[J].Life Sci,2024,336:122326.
[19] DANIEL M,SHEPPARD N,CARLOS G,et al.H vessel formation as a marker for enhanced bone healing in irradiated distraction osteogenesis[J].Semin Plast Surg,2024,38(1):31-38.
[20] KUSUMBE A P,RAMASAMY S K,ADAMS R H.Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone[J].Nature,2014,507(7492):323-328.
[21] HUANG J,YIN H,RAO S S,et al.Harmine enhances type H vessel formation and prevents bone loss in ovariectomized mice[J].Theranostics,2018,8(9):2435-2446.
[22] LI X,FANG S,WANG S,et al.Hypoxia preconditioning of adipose stem cell-derived exosomes loaded in gelatin methacryloyl(GelMA)promote type H angiogenesis and osteoporotic fracture repair[J].J Nanobiotechnology,2024,22(1):112.
[23] WANG L,JIA P,SHAN Y,et al.Synergistic protection of bone vasculature and bone mass by desferrioxamine in osteoporotic mice[J].Mol Med Rep,2017,16(5):6642-6649.
[24] 上官文姬,張躍輝,岳江,等.柚皮苷通過HIF-1α/VEGF信號(hào)促進(jìn)H型血管抗骨質(zhì)疏松的研究[J].中國骨質(zhì)疏松雜志,2022,28(12):1755-1759.
[25] 于海洋,盧增鵬,汪海燕,等.激素性股骨頭壞死中Hif-1α/VEGF信號(hào)軸和H型血管改變的實(shí)驗(yàn)研究[J].中國實(shí)驗(yàn)動(dòng)物學(xué)報(bào),2022,30(6):759-766.
[26] 田佳慶,韋雨柔,肖方駿,等.虎杖苷調(diào)控HIF-1α/VEGF信號(hào)通路對(duì)絕經(jīng)后骨質(zhì)疏松癥大鼠H型血管生成的影響[J].中成藥,2024,46(5):1672-1676.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型
血管內(nèi)皮生長(zhǎng)因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長(zhǎng)因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(09):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(09):20.
[11]周占國,郭浩山,關(guān)濤,等.股骨頭壞死病因的相關(guān)因素分析[J].中醫(yī)正骨,2020,32(01):7.
[12]楊琪,杜炯,孫繼高,等.股骨頭壞死中醫(yī)證型分析[J].中醫(yī)正骨,2020,32(01):14.
[13]許珂,宇文星,宋夢(mèng)歌,等.股骨頭壞死全髖關(guān)節(jié)置換術(shù)患者的人群特征與臨床特點(diǎn)分析[J].中醫(yī)正骨,2020,32(01):51.
[14]李向洲,邢濤,張應(yīng)拴,等.中藥治療激素性股骨頭壞死作用機(jī)制的研究進(jìn)展[J].中醫(yī)正骨,2023,35(02):33.
[15]楊博,邢濤,張應(yīng)拴,等.從伏邪理論論治激素性股骨頭壞死[J].中醫(yī)正骨,2023,35(02):54.
[16]方偉華,莊至坤,彭鵬,等.激素性股骨頭壞死滑膜病變分子機(jī)制的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2024,36(09):49.
FANG Weihua,ZHUANG Zhikun,PENG Peng,et al.Molecular mechanisms of synovial lesions in steroid-induced osteonecrosis of the femoral head:an experimental study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(09):49.
[17]彭鵬,肖歡,方偉華,等.激素性股骨頭壞死囊性變組織骨修復(fù)機(jī)制分析與活血通絡(luò)膠囊含藥血清對(duì)肥大軟骨細(xì)胞成骨分化影響的實(shí)驗(yàn)研究[J].中醫(yī)正骨,2024,36(09):19.
PENG Peng,XIAO Huan,FANG Weihua,et al.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2024,36(09):19.